Avian flu and possible human pandemic

Indian Pediatrics

Volumn 43, Issue 4, 2006, Pages 317-325

  Lahariya, Chandrakant ^a   Sharma, A K ^a   Pradhan, S K ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Avian Flu; Containment; H5N1; Human influenza; Oseltamivir; Pandemic

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

ARTICLE; ASIA; AVIAN INFLUENZA; CHEMOPROPHYLAXIS; DEVELOPING COUNTRY; DISEASE COURSE; EPIDEMIOLOGICAL DATA; EUROPE; FATALITY; GENETIC REASSORTMENT; HEALTH ECONOMICS; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INDIA; INFECTION CONTROL; INFLUENZA VIRUS A; MORTALITY; NONHUMAN; POULTRY FARMING; VACCINATION; VIRAL GENETICS; WORLD HEALTH ORGANIZATION;

ANIMALS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; POULTRY;

EID: 33646246152     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. World Health Organization. Avian influenza (bird flu) fact sheet. at http://www.who.int/mediacentre/factsheets/avian_influenza/en/index.html (Accessed on February 24, 2006)
2. Avian influenza A (H5N1). Weekly Epidemiol Rec 2004;79(7):65-70. (Also available at http://www.who.int/wer/2004/en/wer7907.pdf. (Accessed on February 24, 2006)
3. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363: 617-619.
4. Mounts AW, Kwong H, Izurieta HS, Ho Y, Au T, Lee M, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis 1999;180: 505-508.
5. Monto AS. The threat of an avian influenza pandemic. N Eng J Med 2005; 352: 323-324.
6. Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, et al. Genesis of highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004;430:209-213.
7. World Health Organisation. Situation report of confirmed human cases of H5N1 reported to WHO. at http://www.who.int/csr/disease/avian_influenza/country/cases_table_2006_02_20/ en/index.html (Accessed on February 24, 2006)
8. Government of India. Avian influenza; Ministry of health and family welfare press release. at http://mohfw.nic.in/Communi-cation%20to%20States/ Press%20Release%20on%20Avian%20Flu%20dt%20190206.pdf (Accessed on February 24, 2006)
9. World Health organisation. Avian influenza home page. at http://www.who.int/csr/disease/avian_influenza/en/index.html (Accessed on February 24, 2006).
10. Belshe RB. The origin of pandemic influenza-lesson from the 1918 virus. N Eng J Med 2005; 353: 2209-2211.
11. H5N1 Avian influenza: First step toward development of a human vaccine. Weekly Epidemiol Rec 2005;80:277-284. (Also available at http://www.who.int/wer/2005/en/wer8033.pdf. (Accessed on February 24, 2006)
12. World Health Organisation. Influenza fact sheet. at http://www.who.int/mediacentre/factsheets/fs211/en/ (Accessed on February 27, 2006)
13. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis 2002; 2: 145-155. [Erratum, Lancet Infect Dis 2002; 2: 383].
14. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: Implications for control in health care settings. Clin Infect Dis 2003; 37: 1094-1101.
15. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350: 1179-1188.
16. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352: 333-340.
17. Katz JM, Lim W, Bridges CB, Rowe T, Hu-Primmer J, Lu X, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999;180:1763-1770.
18. Liem NT, World Health Organization International Avian Influenza Investigation Team, Vietnam, Lim W. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis 2005; 11: 210-215.
19. Schultsz C, Dong VC, Chau NV, Le NT, Lim W, Thanh TT, et al. Avian influenza H5N1 and healthcare workers. Emerg Infect Dis 2005; 11: 1158-1159.
20. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351 :467-471.
21. Chan PK. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002; 34:Suppl 2:S58-S64.
22. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11: 201-209.
23. Hatta M, Gao P, Halfmann P, Kawaoka Y. molecular basis for higher emergence of Hong Kong H5N1 Influenza A virus in mice. Science 2001; 293: 1840-1842.
24. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, et al. Fatal Avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352: 686-691.
25. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, Peiris M, et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005; 11: 1036-1041.
26. To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 2001; 63: 242-246.
27. Apisarnthanarak A, Kitphati R, Thongphubeth K, Patoomanunt P, Anthanont P, Auwanit W, et al. Atypical avian influenza (H5N1). Emerg Infect Dis 2004;10:1321-1324.
28. World Health Organization. WHO guidelines for clinical management of humans infected by Influenza A (H5N1) at http://www.who.int/csr/disease/avian_influenza/guidelines/ Guidelines_Clinical%20Management_H5N1_rev.pdf (Accessed on February 24, 2006)
29. World Health Organization. Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness. 2005. at http://www.who.int/csr/disease/avian_influenza/guidelines/avian_labtests1.pdf (Accessed on February 24, 2006)
30. World Health Organisation. WHO pandemic influenza draft protocol for rapid response and containment. Also at http://www.who.int/csr/disease/avian_influenza/guidelines/RapidResponse_27%2001. pdf (Accessed on January 28, 2006)
31. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 338: 1405-1412.
32. Derrick JL, Gomersall CD. Protecting healthcare staff from severe acute respiratory syndrome: Filtration capacity of multiple surgical masks. J Hosp Infect 2005; 59: 365-368.
33. Buxton Bridges C, Katz JM, Seto WH, Chan PK, Tsang D, Ho W, et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 2000; 181: 344-348.
34. Leneva IA, Roberts N, Govorkova EA, Goloubeva OG, Webster RG. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. Antiviral Res 2000; 48: 101-115.
35. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003; 51:123-129.
36. Hedrick JA, Barzilai A, Behre U, Henderson FW, Hammond J, Reilly L, et al. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J 2000; 19: 410-417.
37. Moscova A. Neuraminidase inhibitor for influenza. N Eng J Med 2005; 353: 1363-1373.
38. Hayden FG. Pandemic influenza: is an antiviral response realistic? Pediatr Infect Dis J 2004; 23:Suppl:S262-S269.
39. India Today. Avian Fear. March 6, 2006, New Delhi:22-25
40. Bloom E, de Wit V, San Jose MJC. Potential economic impact of Avian flu pandemic in Asia. ERD policy brief series no. 42. Asian development Bank. Manila. Also at http://www.adb.org/media/articles/2005/8716_Asia_avian_flu/avianflu.pdf (Accessed on March 01, 2006)
41. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect dis 1999; 5: 659-671.